References - Therapeutic Strategies in Cancer Biology and Pathology - page 236

Oates, A.J., Barraclough, R., Rudland, P.S., 1996. The identification of osteopontin as a metas-
tasis-related gene product in a rodent mammary tumour model. Oncogene 13, 97-104.
Obrador-Hevia, A., Serra-Sitjar, M., Rodriguez, J., Villalonga, P., Fernandez de Mattos, S.,
2012. The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma prolif-
eration and survival. Br. J. Haematol. 156, 334-345.
O'Brien, C.A., Pollet, A., Gallinger, S., Dick, J.E., 2007. A human colon caner cell capable of
initiating tumour growth in immunodeficient mice. Nature 445, 106-110.
Ochiai, K., Watanabe, M., Ueki, H., Huang, P., Fujii, Y., Nasu, Y., et al., 2011. Tumor suppres-
sor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1. Biochem. Biophys. Res.
Commun. 412, 391-395.
Ogasawara, S., Maesawa, C., Yamamoto, M., Akiyama, Y., Wada, K., Fujisawa, K., et al.,
2004. Disruption of cell-type-specific methylation at the Maspin gene promoter is fre-
quently involved in undifferentiated thyroid cancers. Oncogene 23, 1117-1124.
Ogden, S.K., Fei, D.L., Schilling, N.S., Ahmed, Y.F., Hwa, J., Robbins, D.J., 2008. G protein
G alpha(i) functions immediately downstream of smoothened in Hedgehog signalling.
Nature 456, 967-970.
Ogihara, T., Isobe, T., Ichimura, T., Taoka, M., Funaki, M., Sakoda, H., et al., 1997. 14-3-3
protein binds to insulin receptor substrate-1, one of the binding sites of which is in the
phophotyrosine binding domain. J. Biol. Chem. 272, 25267-25274.
Ogmundsdottir, H.M., Gudlaugsdottir, S., Bjornsson, J., Jonasdottir, S., 1996. Altered expres-
sion of CA-125 in breast carcinomas. APMIS 104, 47-53.
Ogunjimi A. A., Zeqiraj E., Ceccarelli D. F., Sicheri F., Wrana J. L., David L., 2012. Structural
basis for specificity of TGFbeta family receptor small molecule inhibitors. Cell Signal.
24, 476-483.
Oh, J.S., Kim, J.J., Byun, J.Y., Kim, I.A., 2010. Lin28-Let7 modulates radiosensitivity of
human cancer cells with activation of K-ras. Int. J. Radiat. Oncol. Biol. Phys. 76, 5-8.
Ohashi, S., Natsuizaka, M., Wong, G.S., Michaylira, C.Z., Grugan, K.D., Stairs, D.B., et al.,
2010. Epidermal growth factor receptor and mutant p53 expand an esophageal cellular
subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription
factors. Cancer Res. 70, 4174-4184.
Ohike, N., Maass, N., Mundhenke, C., Biallek, M., Zhang, M., Jonat, W., et al., 2003.
Clinicopathological significance and molecular regulation of maspin expression in ductal
adenocarcinoma of the pancreas. Cancer Lett. 199, 193-200.
Ohno, T., Shirakami, Y., Shimizu, M., Kubota, M., Sakai, H., Yasuda, Y., et al., 2012.
Synergistic growth inhibition of human hepatocellular carcinoma cells by acyclic retinoid
and GW4064, a farnesoid X receptor ligand. Cancer Lett. 323, 215-222.
Ohta, K., Ito, A., Kuriyama, S., Lupo, G., Kosaka, M., Ohnuma, S.I., et al., 2011. Tsukushi
functions as a Wnt signaling inhibitor by competing with Wnt2b for binding to trans-
membrane protein Frizzled4. Proc. Natl. Acad. Sci. U.S.A. 108, 14962-14967.
Ohtaki, T., Shintani, Y., Honda, S., Matsumoto, H., Hori, A., Kanehashi, K., et al., 2001.
Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled recep-
tor. Nature 411, 613-617.
Okada, T., Lopez-Lago, M., Giancotti, F.G., 2005. Merlin/NF-2 mediates contact inhibition
of growth by suppressing recruitment of Rac to the plasma membrane. J. Cell Biol. 171,
361-367.
Okuda, K., Sasaki, H., Hikosaka, Y., Kawano, O., Moriyama, S., Yano, M., et al., 2011. LKB1
gene alterations in surgically resectable adenocarcinoma of the lung. Surg. Today 41,
107-110.